Clinical and Paraclinical Predictors of Survival in Amyotrophic Lateral Sclerosis: Results from a Three-Year Longitudinal Cohort Study
Medical Sciences · 2025
DOI: 10.3390/medsci13030170 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Medical Sciences, 2025. Verfasst von Anca Motataianu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, University of Medicine, Pharmacy, Science and Technology "George Emil Palade" Targu Mures, Gh. Marinescu Str., No. 38, Mures, 5…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Amyotrophic Lateral Sclerosis (ALS) is a heterogeneous neurodegenerative disorder with highly variable progression and survival. Identifying early prognostic indicators is essential for patient stratification and management.
Objectives
To evaluate clinical, respiratory, and functional predictors of survival in a prospective cohort of ALS patients over a three-year period.
Methods
A cohort of 44 ALS patients was followed from 2022 to 2025. Demographic and anthropometric characteristics, clinical data including ALS subtypes and phenotypes, site of onset, revised ALS functional rating scale (ALSFRS-R) and subscores, ALSFRS-R progression rate, time to diffusion and generalization, spirometric parameters, and progression patterns were assessed. Survival analysis was performed using Kaplan–Meier estimates and univariate and multivariate Cox proportional hazard regression analysis.
Results
The overall median survival time was 53 months. Univariate Cox regression revealed that older age at onset, shorter diagnostic delay, lower respiratory function, lower vitamin D levels, and rapid vertical progression were associated with reduced survival. Bulbar-onset phenotype and rapid disease progression rate (ΔPR) were significant predictors of mortality. Specific ALSFRS-R subscores also showed prognostic relevance. A longer time to diffusion as well as a longer time to generalization were significantly associated with prolonged survival. Multivariate analysis confirmed the independent prognostic value of ΔPR, time to diagnosis, and ALSFRS-R swallowing and handwriting subscores.
Conclusions
This study supports the prognostic value of previously studied clinical and paraclinical markers in ALS and proposes novel predictors, ALSFRS-R handwriting, and time to diffusion, which require further validation in larger prospective cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neurology Department, University of Medicine, Pharmacy, Science and Technology "George Emil Palade" Targu Mures, Gh. Marinescu Str., No. 38, Mures, 540142 Targu Mures, Romania.
- Neurology 1 Clinic, Emergency Clinical County Hospital Targu Mures, 540136 Targu Mures, Romania.
Zitieren
APA
Motataianu, A., Barcutean, L., Ormenisan, I., Roman, M., Balasa, R., Bajko, Z., & Dumitreasa, M. (2025). Clinical and Paraclinical Predictors of Survival in Amyotrophic Lateral Sclerosis: Results from a Three-Year Longitudinal Cohort Study. Medical Sciences. https://doi.org/10.3390/medsci13030170
Vancouver
Motataianu A, Barcutean L, Ormenisan I, Roman M, Balasa R, Bajko Z, et al. Clinical and Paraclinical Predictors of Survival in Amyotrophic Lateral Sclerosis: Results from a Three-Year Longitudinal Cohort Study. Medical Sciences. 2025. doi:10.3390/medsci13030170
BibTeX
@article{Motataianu2025,
author = {Motataianu, Anca and Barcutean, Laura and Ormenisan, Ioana and Roman, Medeea and Balasa, Rodica and Bajko, Zoltan and Dumitreasa, Mihai},
title = {Clinical and Paraclinical Predictors of Survival in Amyotrophic Lateral Sclerosis: Results from a Three-Year Longitudinal Cohort Study},
journal = {Medical Sciences},
year = {2025},
doi = {10.3390/medsci13030170}
}
EUVIMED